Publication & Citation Trends
Publications
0 total
AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization.
Cited by 53
Semantic Scholar
Macrocyclic BACE-1 inhibitors acutely reduce Abeta in brain after po application.
Cited by 51
Semantic Scholar
Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst(3) receptor antagonists.
Cited by 17
Semantic Scholar
Discovery of novel non-peptidic beta-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists.
Cited by 11
Semantic Scholar
Similar Rivastigmine Pharmacokinetics and Pharmacodynamics in Japanese and White Healthy Participants Following the Application of Novel Rivastigmine Patch
Cited by 25
Semantic Scholar
The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
Cited by 139
Semantic Scholar
Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.
Cited by 24
Semantic Scholar
Muscarinic Acetylcholine Receptors
Cited by 0
Semantic Scholar
M4 Muscarinic Acetylcholine Receptor
Cited by 0
Semantic Scholar
Research Topics
Cholinesterase and Neurodegenerative Diseases
(38)
Neuroscience and Neuropharmacology Research
(18)
Receptor Mechanisms and Signaling
(18)
Nicotinic Acetylcholine Receptors Study
(15)
Chemical synthesis and alkaloids
(15)
Affiliations
Novartis (Switzerland)
Sanden (Japan)
Psychiatry Baselland
Novartis (United States)
Jain PharmaBiotech (Switzerland)